
### [NCIT:C9128](http://purl.obolibrary.org/obo/NCIT_C9128)
**Label:** Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

**Subclasses:** 

**Class expressions from DL-Learner:**

- [NCIT:C36341](http://purl.obolibrary.org/obo/NCIT_C36341) (Signal Transduction Pathway Deregulation) 56.45%
- Thing 54.46%
- [NCIT:C38347](http://purl.obolibrary.org/obo/NCIT_C38347) (P13K-AKT Pathway Deregulation) 51.61%
- [NCIT:C38346](http://purl.obolibrary.org/obo/NCIT_C38346) (MYC Pathway Deregulation) 51.61%
- [NCIT:C38345](http://purl.obolibrary.org/obo/NCIT_C38345) (JUN Pathway Deregulation) 51.61%
- [NCIT:C38344](http://purl.obolibrary.org/obo/NCIT_C38344) (RAS-RAF Pathway Deregulation) 51.61%
- [NCIT:C38343](http://purl.obolibrary.org/obo/NCIT_C38343) (JAK-STAT Pathway Deregulation) 51.61%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) and (not ([NCIT:C39583](http://purl.obolibrary.org/obo/NCIT_C39583) (FAS Apoptosis Pathway Deregulation))) 47.59%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) and (not ([NCIT:C36339](http://purl.obolibrary.org/obo/NCIT_C36339) (Cell Cycle Deregulation))) 47.59%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) 45.33%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) and (not ([NCIT:C40255](http://purl.obolibrary.org/obo/NCIT_C40255) (Vaginal Mullerian Papilloma))) 45.33%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) and (not ([NCIT:C40252](http://purl.obolibrary.org/obo/NCIT_C40252) (Vaginal Mucinous Adenocarcinoma))) 45.33%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) and (not ([NCIT:C40251](http://purl.obolibrary.org/obo/NCIT_C40251) (Vaginal Endometrioid Adenocarcinoma))) 45.33%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) and (not ([NCIT:C40248](http://purl.obolibrary.org/obo/NCIT_C40248) (Vaginal Warty Carcinoma))) 45.33%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) and (not ([NCIT:C40245](http://purl.obolibrary.org/obo/NCIT_C40245) (Vaginal Basaloid Carcinoma))) 45.33%


